Ceftazidime-Avibactam Resistant, Meropenem Sensitive KPC-Producing IKlebsiella pneumoniae/I in ICU S...
Ceftazidime-Avibactam Resistant, Meropenem Sensitive KPC-Producing IKlebsiella pneumoniae/I in ICU Setting: We Are What We Are Treated with?
About this item
Full title
Author / Creator
Publisher
MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
MDPI AG
Subjects
More information
Scope and Contents
Contents
The continuous spread of carbapenem-resistant Klebsiella pneumoniae (CP-Kp) strains presents a severe challenge to the healthcare system due to limited therapeutic options and high mortality. Since its availability, ceftazidime/avibactam (C/A) has become a first-line option against KPC-Kp, but C/A-resistant strains have been reported increasingly,...
Alternative Titles
Full title
Ceftazidime-Avibactam Resistant, Meropenem Sensitive KPC-Producing IKlebsiella pneumoniae/I in ICU Setting: We Are What We Are Treated with?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A751925969
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A751925969
Other Identifiers
ISSN
1422-0067
DOI
10.3390/ijms24054767
